Dopamine neurotransmission controls motor and perseverative behavior, is mediated by protein phosphorylation, and may be perturbed in disorders of attention and hyperactivity. To assess the role of casein kinase I (CK1) in the regulation of dopamine signaling, we generated a genetically modified mouse line that overexpresses CK1δ (CK1δ OE) specifically in the forebrain. Overexpression was confirmed both at the mRNA and at the protein levels. Under basal conditions, CK1δ OE mice exhibited horizontal and vertical hyperactivity, reduced anxiety, and nesting behavior deficiencies. The CK1δ OE mice also presented paradoxical responses to dopamine receptor stimulation, showing hypoactivity following injection of d-amphetamine or methylphenidate, indicating that CK1 activity has a profound effect on dopamine signaling in vivo. Interestingly, CK1δ overexpression led to significantly reduced D1R and D2R dopamine receptor levels. All together, under basal conditions and in response to drug stimulation, the behavioral phenotype of CK1δ OE mice is reminiscent of the symptoms and drug responses observed in attention-deficit/hyperactivity disorder and therefore the CK1δ OE mice appear to be a model for this disorder.CK1 | D1R | methylphenidate | protein kinase amphetamine C asein kinase 1 (CK1) represents an evolutionarily conserved eukaryotic protein kinase family consisting of several isoforms including CK1δ, which is one of the most enriched in brain. The CK1 Ser/Thr kinase family plays a crucial role in numerous biological functions ranging from cell cycle regulation (1-5) to more complex behavioral traits (6-8). In the central nervous system, CK1δ is involved in a variety of physiological (e.g., cell signaling, circadian rhythm, cellular trafficking) and pathological (e.g., amyloid-β formation and tauopathies) processes (9-14). In the basal ganglia, CK1 regulates the state of phosphorylation of DARPP-32 (dopamine-and cAMP-regulated phospho-protein Mw of 32 kDa), a key striatal protein, which integrates synaptic input signals from various origins including the dopaminergic and glutamatergic systems (15-17). Imbalance of dopamine neurotransmission in the nigrostriatal pathway has been linked to various neurodevelopmental disorders, such as attention-deficit/ hyperactivity disorder (ADHD) (18)(19)(20)(21)(22). Indeed, the frontostriatal network has been largely implicated in the occurrence of the cardinal features of ADHD, which are hyperactivity, inattention, and impulsivity (for a review see ref. 23).In addition to regulation of DARPP-32, CK1 is likely to influence other aspects of neuronal function. The consensus sequence for CK1-dependent phosphorylation is well established (24, 25). However, the frequent requirement for a phospho-Ser or phosphoThr residue close to the site actually phosphorylated by CK1 makes it challenging to predict if a given protein will be phosphorylated by CK1. Moreover, existing CK1 inhibitors are not brain permeable. To circumvent these caveats, we chose to investigate the physiological importa...